BECOME THE LEADING INVESTMENT FUND FOR CANNABIS PHARMA, MEDICAL DEVICE & MEDICAL CANNABIS INNOVATIONS
We represent the first Cannabis pharmaceuticals company sold in Israel.
Exclusive Biotech Venture Capital
CannaDu is an exclusive Biotech Venture Capital fund, focused on Cannabis investments in fields of Pharmaceuticals, wellness, medical applications & devices.
Becoming The leading Biotech Cannabis investments fund in Israel.
Based upon the founder’s reputation, deep understanding of the cannabis industry and 6+ years of experience in the field, CannaDu is strategically positioned to become the leading Biotech investment fund within the Cannabis investments domain in Israel.
The Fund’s Leading Team:
The fund’s leading team includes its Chairman, David Bassa, who made the only exit so far in the Israeli Pharma/medical/wellness ecosystem,
and the fund‘s CEO, Ofer Spottheim, one of the most experienced and prominent individuals in the Israeli cannabis ecosystem.
We know that Cannabis and its derivatives are an almost undiscovered and untapped fortune of healing potential.
We therefore intend to continue to discover and support the most promising companies in the field, while ensuring substantial ROI’s for our investors